Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa: a neuroimaging study

Joan Crespi, Daniel Bratbak, David William Dodick, Manjit Matharu, Kent Are Jamtøy, Irina Aschehoug, Erling Tronvik

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Historical reports describe the sphenopalatine ganglion (SPG) as positioned directly under the nasal mucosa. This is the basis for the topical intranasal administration of local anaesthetic (LA) towards the sphenopalatine foramen (SPF) which is hypothesized to diffuse a distance as short as 1 mm. Nonetheless, the SPG is located in the sphenopalatine fossa, encapsulated in connective tissue, surrounded by fat tissue and separated from the nasal cavity by a bony wall. The sphenopalatine fossa communicates with the nasal cavity through the SPF, which contains neurovascular structures packed with connective tissue and is covered by mucosa in the nasal cavity. Endoscopically the SPF does not appear open. It has hitherto not been demonstrated that LA reaches the SPG using this approach. Methods: Our group has previously identified the SPG on 3 T–MRI images merged with CT. This enabled us to measure the distance from the SPG to the nasal mucosa covering the SPF in 20 Caucasian subjects on both sides (n = 40 ganglia). This distance was measured by two physicians. Interobserver variability was evaluated using the intraclass correlation coefficient (ICC). Results: The mean distance from the SPG to the closest point of the nasal cavity directly over the mucosa covering the SPF was 6.77 mm (SD 1.75; range, 4.00–11.60). The interobserver variability was excellent (ICC 0.978; 95% CI: 0.939–0.990, p < 0.001). Conclusions: The distance between the SPG and nasal mucosa over the SPF is longer than previously assumed. These results challenge the assumption that the intranasal topical application of LA close to the SPF can passively diffuse to the SPG.

Original languageEnglish (US)
Article number14
JournalJournal of Headache and Pain
Volume19
Issue number1
DOIs
StatePublished - Dec 1 2018

Fingerprint

Nasal Mucosa
Neuroimaging
Ganglia
Nasal Cavity
Local Anesthetics
Observer Variation
Connective Tissue
Mucous Membrane
Topical Administration
Intranasal Administration
Fats
Physicians

Keywords

  • Block
  • Intranasal
  • Local anaesthetics
  • Pterygopalatine ganglion
  • Sphenopalatine ganglion

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa : a neuroimaging study. / Crespi, Joan; Bratbak, Daniel; Dodick, David William; Matharu, Manjit; Jamtøy, Kent Are; Aschehoug, Irina; Tronvik, Erling.

In: Journal of Headache and Pain, Vol. 19, No. 1, 14, 01.12.2018.

Research output: Contribution to journalArticle

Crespi, Joan ; Bratbak, Daniel ; Dodick, David William ; Matharu, Manjit ; Jamtøy, Kent Are ; Aschehoug, Irina ; Tronvik, Erling. / Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa : a neuroimaging study. In: Journal of Headache and Pain. 2018 ; Vol. 19, No. 1.
@article{45bed69e1fae431f9680ff5564cf664d,
title = "Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa: a neuroimaging study",
abstract = "Background: Historical reports describe the sphenopalatine ganglion (SPG) as positioned directly under the nasal mucosa. This is the basis for the topical intranasal administration of local anaesthetic (LA) towards the sphenopalatine foramen (SPF) which is hypothesized to diffuse a distance as short as 1 mm. Nonetheless, the SPG is located in the sphenopalatine fossa, encapsulated in connective tissue, surrounded by fat tissue and separated from the nasal cavity by a bony wall. The sphenopalatine fossa communicates with the nasal cavity through the SPF, which contains neurovascular structures packed with connective tissue and is covered by mucosa in the nasal cavity. Endoscopically the SPF does not appear open. It has hitherto not been demonstrated that LA reaches the SPG using this approach. Methods: Our group has previously identified the SPG on 3 T–MRI images merged with CT. This enabled us to measure the distance from the SPG to the nasal mucosa covering the SPF in 20 Caucasian subjects on both sides (n = 40 ganglia). This distance was measured by two physicians. Interobserver variability was evaluated using the intraclass correlation coefficient (ICC). Results: The mean distance from the SPG to the closest point of the nasal cavity directly over the mucosa covering the SPF was 6.77 mm (SD 1.75; range, 4.00–11.60). The interobserver variability was excellent (ICC 0.978; 95{\%} CI: 0.939–0.990, p < 0.001). Conclusions: The distance between the SPG and nasal mucosa over the SPF is longer than previously assumed. These results challenge the assumption that the intranasal topical application of LA close to the SPF can passively diffuse to the SPG.",
keywords = "Block, Intranasal, Local anaesthetics, Pterygopalatine ganglion, Sphenopalatine ganglion",
author = "Joan Crespi and Daniel Bratbak and Dodick, {David William} and Manjit Matharu and Jamt{\o}y, {Kent Are} and Irina Aschehoug and Erling Tronvik",
year = "2018",
month = "12",
day = "1",
doi = "10.1186/s10194-018-0843-5",
language = "English (US)",
volume = "19",
journal = "Journal of Headache and Pain",
issn = "1129-2369",
publisher = "Springer-Verlag Italia",
number = "1",

}

TY - JOUR

T1 - Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa

T2 - a neuroimaging study

AU - Crespi, Joan

AU - Bratbak, Daniel

AU - Dodick, David William

AU - Matharu, Manjit

AU - Jamtøy, Kent Are

AU - Aschehoug, Irina

AU - Tronvik, Erling

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Background: Historical reports describe the sphenopalatine ganglion (SPG) as positioned directly under the nasal mucosa. This is the basis for the topical intranasal administration of local anaesthetic (LA) towards the sphenopalatine foramen (SPF) which is hypothesized to diffuse a distance as short as 1 mm. Nonetheless, the SPG is located in the sphenopalatine fossa, encapsulated in connective tissue, surrounded by fat tissue and separated from the nasal cavity by a bony wall. The sphenopalatine fossa communicates with the nasal cavity through the SPF, which contains neurovascular structures packed with connective tissue and is covered by mucosa in the nasal cavity. Endoscopically the SPF does not appear open. It has hitherto not been demonstrated that LA reaches the SPG using this approach. Methods: Our group has previously identified the SPG on 3 T–MRI images merged with CT. This enabled us to measure the distance from the SPG to the nasal mucosa covering the SPF in 20 Caucasian subjects on both sides (n = 40 ganglia). This distance was measured by two physicians. Interobserver variability was evaluated using the intraclass correlation coefficient (ICC). Results: The mean distance from the SPG to the closest point of the nasal cavity directly over the mucosa covering the SPF was 6.77 mm (SD 1.75; range, 4.00–11.60). The interobserver variability was excellent (ICC 0.978; 95% CI: 0.939–0.990, p < 0.001). Conclusions: The distance between the SPG and nasal mucosa over the SPF is longer than previously assumed. These results challenge the assumption that the intranasal topical application of LA close to the SPF can passively diffuse to the SPG.

AB - Background: Historical reports describe the sphenopalatine ganglion (SPG) as positioned directly under the nasal mucosa. This is the basis for the topical intranasal administration of local anaesthetic (LA) towards the sphenopalatine foramen (SPF) which is hypothesized to diffuse a distance as short as 1 mm. Nonetheless, the SPG is located in the sphenopalatine fossa, encapsulated in connective tissue, surrounded by fat tissue and separated from the nasal cavity by a bony wall. The sphenopalatine fossa communicates with the nasal cavity through the SPF, which contains neurovascular structures packed with connective tissue and is covered by mucosa in the nasal cavity. Endoscopically the SPF does not appear open. It has hitherto not been demonstrated that LA reaches the SPG using this approach. Methods: Our group has previously identified the SPG on 3 T–MRI images merged with CT. This enabled us to measure the distance from the SPG to the nasal mucosa covering the SPF in 20 Caucasian subjects on both sides (n = 40 ganglia). This distance was measured by two physicians. Interobserver variability was evaluated using the intraclass correlation coefficient (ICC). Results: The mean distance from the SPG to the closest point of the nasal cavity directly over the mucosa covering the SPF was 6.77 mm (SD 1.75; range, 4.00–11.60). The interobserver variability was excellent (ICC 0.978; 95% CI: 0.939–0.990, p < 0.001). Conclusions: The distance between the SPG and nasal mucosa over the SPF is longer than previously assumed. These results challenge the assumption that the intranasal topical application of LA close to the SPF can passively diffuse to the SPG.

KW - Block

KW - Intranasal

KW - Local anaesthetics

KW - Pterygopalatine ganglion

KW - Sphenopalatine ganglion

UR - http://www.scopus.com/inward/record.url?scp=85042082559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042082559&partnerID=8YFLogxK

U2 - 10.1186/s10194-018-0843-5

DO - 10.1186/s10194-018-0843-5

M3 - Article

C2 - 29442191

AN - SCOPUS:85042082559

VL - 19

JO - Journal of Headache and Pain

JF - Journal of Headache and Pain

SN - 1129-2369

IS - 1

M1 - 14

ER -